Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus placebo for cellulitis
ISRCTN76873478Phase 3Active, not recruiting
- Sponsor
- North Bristol NHS Trust
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in cellulitis comparing Dexamethasone plus usual care with Placebo plus usual care (2 arms). Primary endpoint: Pain numerical rating scale. Started Feb 2025; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
cellulitis
Beyond the preview
Go deeper on ISRCTN76873478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76873478.